Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors

BACKGROUND: It remains not well known whether skeletal muscle mass (SMM) loss has any impact on the effectiveness of immune checkpoint inhibitors (ICIs) in patients with advanced lung cancer. We aimed to evaluate the association between SMM and clinical outcome of patients with advanced lung cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuluan, Liu, Zhou, Ren, Ya, Liu, Jinying, Lv, Shiqi, He, Pin, Yang, Yajing, Sun, Yanfen, Chang, Jianhua, Luo, Dehong, Cong, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339782/
https://www.ncbi.nlm.nih.gov/pubmed/35923193
http://dx.doi.org/10.3389/fnut.2022.900823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339782/
https://www.ncbi.nlm.nih.gov/pubmed/35923193
http://dx.doi.org/10.3389/fnut.2022.900823

Ejemplares similares